硅谷银行-2020年第四季度风险监测报告.docx
《硅谷银行-2020年第四季度风险监测报告.docx》由会员分享,可在线阅读,更多相关《硅谷银行-2020年第四季度风险监测报告.docx(38页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、Silicon Valley BankBuilt for Whats Next.Helping life science and healthcare innovators move bold ideas forward, fast.For 35 years, Silicon Valley Bank has been at the intersection of innovation and capital. We provide unique access to insights and strategies for companies of all sizes in innovation
2、centers around the world all designed to help you find whafs next.svb 2020 SVB Financial Group. All Rights Reserved. Silicon Valley Bank Member FDIC.Ecosystems adapt to shifting industry trendsUS VC deal activity in 2020 by CSASeattle DeaGHFit: 366、(-14.3% YoY change)/Deal value: $4.5B 1I.Minneapoli
3、s Deal cnunt: 114(-4.2% YoY change) Deal count: $1.6B +2.3% YoY change).Minneapolis Deal cnunt: 114(-4.2% YoY change) Deal count: $1.6B +2.3% YoY change)(+14.0% YoY change)IBay AreaDeal count: 2,503(-13.3% YoY change)Deal value: $61.5BIl 8.8% YoY change)DenverDeal count: 329(-1 1.1 % YoY change)Deal
4、 value: $2.6B(+4.4% YoY change)Chicag?Deal count: 273(-10.8% YoY change)Deal value: $2.8B(+21.5% YoY change)% YoY change) Deal value: $19.3B (-16.9% YoY change)Los Angeles *1 count: 1,126*2必Qange)AtlantaDeal count::(+l.l%YoYcjDeal value:1AustinDeal count: 260(-15.3% YoY change)Deal value: $2.3BYoY c
5、hange)PitchBook-NVCA Venture MonitorDespite record year for fundraising, capital still consolidates in main tech hubsFundraising trends largely unchangedoooCMCMCMoooCMCMCNCMO CMNashville Salt Lake City MiamiSeattle Los Angeles New York Chicago Washington, DC Boston Bay Area OtherPitchBook-NVCA Ventu
6、re MonitorPitchBook-NVCA Venture MonitorRecord-shattering year for biotech & pharmaUS VC biotech & pharma deal activityNear-even split of biotech & pharma deals across stagesUS VC biotech & pharma deals (#) by stage Late VC Early VCAngel & seedS 寸 C9C86。 11OOOOOOOO 77nzz ZCNC1% ooooo oooooo 09876543
7、21FEEDeal value ($B)Deal count。一。ePitchBook-NVCA Venture MonitorPitchBook-NVCA Venture Monitor$30$25$20$15$10$5$0ooooooooooo$0Notable increases seen in both median and average deal sizeMedian and average US VC biotech & pharma deal sizes ($M) $35Median and average valuations sitting at all- time hig
8、hsMedian and average US VC biotech & pharma pre-money valuations ($M) $160$140$120$100$80$60$40$20Fintech VC deals exceed $20B in record yearUS VC fintech deal activityAngel and seed deal contraction offset by expansion of I a testa ge dealsUS VC fintech deals (#) by stage198359281780637699649493寸SS
9、 寸一 S 5OS9107 SIOZ 寸I0Z E-oz z-oz 二 0Z 0I0ZDeal value ($B)1,029 1031寸 寸 为Deal count938O ci so g Cl100%90%80%70%60%50%40%Late VC Early VC Angel & seed(NON 6 一 ON 810Z ZJOC 9I0Z s-oe 寸一 oe E-oe zioe 二 oe o 一 ON % % % % o o o o 3 2 1PitchBook-NVCA Venture MonitorPitchBook-NVCA Venture MonitorSeveral ou
10、tsized deals push average higherMedian and average US VC fintech deal sizes ($M)Frothy fintech valuations cause average to skyrocketMedian and average US VC fintech pre-money valuations ($M)“o 5,428 4,友oeoCN6 一 OZ8 1 oeZJOZ9 1 oes-oz寸一 ONE-oezioe二 ON。一oeDeal value ($B)Deal countoooooooooooPitchBook-
11、NVCA Venture MonitorB2B tech received record investment value in 2020US VC B2B tech deal activityPitchBook-NVCA Venture Monitor32% of B2B deals completed at late stageAverage deal value up significantlyMedian and average US VC B2Btech deal sizes ($M)Average valuation surgedMedian and average US VC B
12、2Btech pre-money valuations ($M)Headwinds hit consumer techBroader stage trends match B2ctechUS VC B2C tech deals (#) by stageUS VC B2C tech deal activityDeal value ($B)Deal count100%90%80%70%60%50%40%30%20% Late VC Early VC Angel & seedoeoe6 一 ON8I0NZJOZs-oz寸一 0(Ns-oz(N-oz二 oz。一ONPitchBook-NVCA Ven
13、ture MonitorPitchBook-NVCA Venture MonitorDeal sizes see bounce in 2020Median and average US VC B2C tech deal sizes ($M)$25$308.9Average pre-money valuation reaches new highMedian and average US VC B2C tech pre-money valuations ($M)$350$300$250$200$150$100$50$0SVB: Why SPACs now?The return of the SP
14、AC certainly made waves in 2020, leading many high-profile investors to sponsor tech-focused SPACs. We are taking a look at the phenomenon through the lens of whats in it for longterm investors. Exit activity across the board is making for a lot of happy investors, and SPACs have a lot to do with th
15、e tsunami of capital raised in the public markets in the second half of a most unpredictable 2020.At the dawn of 2020, there was a lot of talk about direct listings and other alternative paths to take companies public. The traditional IPO had run its course, or so some opined. But few predicted how
16、companies are SPACing their way to billion-dollar-plus valuations or how, even amid a pandemic, traditional IPOs are springing back to life.SPAC activity in 2020 smashed records, involving 250 companies that collectively raised $75.1 billion, compared to 2019 when 53 SPACs raised $11.1 billion. In 2
17、020z 102 traditional IPOs raised $222 billion.Why SPACs now? The IPO process has seen little innovation, and for some companies thinking about going public, SPACs can provide useful tools to raise capital quicker and with fewer hurdles based on current market conditions. SPACs may offer an opportuni
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 硅谷 银行 2020 第四 季度 风险 监测 报告
限制150内